L-alanine supplementation in late infantile glycogen storage disease type II

Olaf A. Bodamer, Dorothea Haas, Monique M. Hermans, Arnold J. Reuser, Georg F. Hoffmann

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

We report a male with late infantile glycogen storage disease type II (Pompe's disease) who presented at 12 months of age with muscular hypotonia and developmental delay. Oral supplementation with L-alanine has been administered for 5 years. Progression of skeletal myopathy was slow, and cardiomyopathy resolved almost completely. L-alanine may be a valuable supplement for infants with glycogen storage disease type II.

Original languageEnglish (US)
Pages (from-to)145-146
Number of pages2
JournalPediatric Neurology
Volume27
Issue number2
DOIs
StatePublished - Aug 2002

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Developmental Neuroscience
  • Clinical Neurology

Fingerprint Dive into the research topics of 'L-alanine supplementation in late infantile glycogen storage disease type II'. Together they form a unique fingerprint.

Cite this